Les Publications
|
|
|
|
|
|
|
|
GERCOR : ASCO 2002 |
|
Abstracts ASCO 2002
|
|
- Gramont A, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Davidson N, Mounedji-Boudiaf L, Andre T, Hopital Saint-Antoine, Paris, France; Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; Hospital Duran i Reynals, Llobregat, Spain; Hospital Vall d'Hebron, Barcelona, Spain; Royal Bournemouth Hospital, Bournmouth, UK; St Luke's Cancer Center, Royal Surrey County Hospital, Guildford, UK; Ospedale di Legnago, Legnago, Italy; Illawara Cancer Care Center, Wollongong, Australia; North Middlesex Hospital, London, UK; Sanofi-Synthelabo, Paris, France; Hopital Tenon, Paris, France. Oxaliplatin/5-FU/LV in adjuvant colon cancer: safety results of the international randomized MOSAIC trial. Proc Am Clin Oncol 2002; 21:133a (abst 525).
- Andre T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E, Colbert N, Boaziz C, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Quinaux E, Buyse M and de Gramont A. For the GERCOR Group, Paris France. Phase III trial (GERCOR C96.1) comparing bimonthly LV5FU2 to monthly 5FU-leucovorin high dose (LV hd) for 24 or 36 weeks in patients with dukes’ B2 and C colon cancer. first report of efficacy. Proc Am Clin Oncol 2002; 21:133a (abst 529).
- Maindrault F, Louvet C, Tournigand C, Gervais H, Mabro M, Artru P, Garcia ML, Andre T, Carola E, de Gramont A, Hopital St-Antoine, Paris, France; Hopital Tenon, Paris, France; Hopital de Senlis, Senlis, France. Leucovorin, 5-fluorouracil infusion and irinotecan (folfiri-3) in pretreated patients with metastatic colorectal cancer. Proc Am Clin Oncol 2002; 21:133a (abst 658).
- Artru P, Taieb J, Tournigand C, Louvet C, Hafraoui S, Paye F, Maindrault F, Parc R, Gayet B, Molitor JL, de Gramont A, Hopital St-Antoine, Paris, France; Inst Mutualiste Montsouris, Paris, France. FOLFOX7 / FOLFIRI (MIROX) Regimen as (neo)adjuvant chemotherapy for patients with resectable metastatic colorectal cancer : preliminary results Proc Am Clin Oncol 2002; 21:133a (abst 672).
- Gervais H, Artru P, Louvet C, Tournigand C, Maindrault F, Garcia M, de Gramont A, Hopital St-Antoine, Paris, France. Reintroduction of irinotecan in pretreated patients with metastatic colorectal cancer.Proc Am Clin Oncol 2002; 21:133a (abst 688).
- Tournigand C, Louvet C, Molitor JL, Dehni N, Sezeur A, Pigne A, Marpeau L, Cady J, Lejeune V, Garcia ML, de Gramont A, Hopital Saint-Antoine, Paris, France; Hopital des Diaconnesses, Paris, France; Clinique Geoffroy St-Hilaire, Paris, France; Hopital Charles Nicolle, Rouen, France. Consolidation intraperitoneal chemotherapy (IP) in advanced ovarian cancer (AOC) with pathological complete response (PCR) or with microscopical residual disease. A GERCOR study. Proc Am Clin Oncol 2002; 21:133a (abst 883).
|
|
|
|
|
|
|
|
|